1,2,3,4-tetrahydroisoquinoline has been researched along with Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bartolucci, G; Braconi, L; Chiaramonte, N; Colabufo, NA; Contino, M; Dei, S; Giampietro, R; Manetti, D; Perrone, MG; Riganti, C; Romanelli, MN; Teodori, E | 1 |
Cheng, K; Fang, Y; Hua, H; Ji, B; Li, D; Li, H; Li, Z; Wu, B; Zheng, C | 1 |
Shah, P; Singh, IP | 1 |
2 review(s) available for 1,2,3,4-tetrahydroisoquinoline and Neoplasms
Article | Year |
---|---|
Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification.
Topics: Alkaloids; Anti-Infective Agents; Antibiotics, Antineoplastic; Antiprotozoal Agents; Biological Products; Molecular Structure; Neoplasms; Tetrahydroisoquinolines | 2021 |
Tetrahydroisoquinolines in therapeutics: a patent review (2010-2015).
Topics: Animals; Antineoplastic Agents, Alkylating; Central Nervous System Diseases; Dioxoles; Drug Design; Humans; Neoplasms; Patents as Topic; Tetrahydroisoquinolines; Trabectedin | 2017 |
1 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Neoplasms
Article | Year |
---|---|
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers.
Topics: Amides; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Esters; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Tetrahydroisoquinolines | 2020 |